Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety.
Mihirbaran MandalKaushik MitraDiane GrotzXinjie LinJairam PalamandaPramila KumariAlexei V BuevichJohn P CaldwellXia ChenKathleen CoxLeonard FavreauLynn HydeMatthew E KennedyReshma KuvelkarXiaoxiang LiuRobert D MazzolaEric ParkerDiane RindgenEdward C ShererHongwu WangZhaoning ZhuAndrew W StamfordJared N CummingPublished in: Journal of medicinal chemistry (2018)
Herein we describe structure-activity relationship (SAR) and metabolite identification (Met-ID) studies that provided insight into the origin of time-dependent inhibition (TDI) of cytochrome P450 3A4 (CYP3A4) by compound 1. Collectively, these efforts revealed that bioactivation of the fluoropyrimidine moiety of 1 led to reactive metabolite formation via oxidative defluorination and was responsible for the observed TDI. We discovered that substitution at both the 4- and 6-positions of the 5-fluoropyrimidine of 1 was necessary to ameliorate this TDI as exemplified by compound 19.